ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

CTI Cathay International Holdings Ld

0.75
0.00 (0.00%)
19 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Cathay International Holdings Ld LSE:CTI London Ordinary Share BMG1965E1030 COM SHS $0.01
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.75 0.50 1.00 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Cathay International Holdings Ld Result of AGM (7642I)

21/06/2017 11:55am

UK Regulatory


Cathay International Hol... (LSE:CTI)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Cathay International Hol... Charts.

TIDMCTI

RNS Number : 7642I

Cathay International Holdings Ld

21 June 2017

Cathay International Holdings Limited

("Cathay" or the "Company")

Results of Annual General Meeting ("AGM")

Hong Kong, 21 June 2017 - Cathay International Holdings Limited (LSE: CTI.L), an operator and investor in the growing healthcare sector in the People's Republic of China, today announces that at the AGM held earlier today, all resolutions as set out in the Notice of AGM dated 28 April 2017 were duly passed, save for ordinary resolutions numbered 2 and 3 (the "Re-Election Resolutions") which are subject to the dual voting requirements of Listing Rule 9.2.2E. Although the Re-Election Resolutions were approved by a majority of all shareholders, the majority of the votes cast by the independent shareholders were against the Re-Election Resolutions. Accordingly, and pursuant to Listing Rule 9.2.2F, further ordinary resolutions to re-elect the respective directors (Messrs Sum Soon Lim and Kenneth K. Toong) (the "Further Re-Election Resolutions") will be proposed by the Company. The relevant voting will take place on a date to be announced by the Company within a period commencing 90 days from today's date and ending 120 days from today's date. Pursuant to the guidance note at Listing Rule 9.2.2D, Messrs Sum Soon Lim and Kenneth K. Toong shall remain in office until the Further Re-Election Resolutions have been voted upon by all shareholders of the Company. Pursuant to Listing Rule 9.2.2F(3), the Further Re-Election Resolutions must be approved by the shareholders of the Company, without the requirement for separate voting by the independent shareholders. The final poll voting results for each resolution are shown in the table below:

 
 Ordinary resolutions                           For      Against         Total   Withheld 
                                                                         votes 
-------------------------------------  ------------  -----------  ------------  --------- 
 1. Report and Accounts                 396,219,499   41,723,364   437,942,863      5,256 
-------------------------------------  ------------  -----------  ------------  --------- 
 2. Re-election of 
  Mr. Sum Soon Lim 
 
       *    all shareholders            396,217,937   41,728,282   437,946,219      1,900 
 
       *    independent shareholders      6,075,983   41,728,282    47,804,265      1,900 
-------------------------------------  ------------  -----------  ------------  --------- 
 3. Re-election of 
  Mr. Kenneth K. Toong 
 
       *    all shareholders            396,219,887   41,726,332   437,946,219      1,900 
 
       *    independent shareholders      6,077,933   41,726,332    47,804,265      1,900 
-------------------------------------  ------------  -----------  ------------  --------- 
 4. Reappointment 
  of Auditor                            437,804,293      141,926   437,946,219      1,900 
-------------------------------------  ------------  -----------  ------------  --------- 
 5. Authority to 
  allot new shares                      437,806,260      139,959   437,946,219      1,900 
-------------------------------------  ------------  -----------  ------------  --------- 
 
 
 Special resolutions               For      Against         Total   Withheld 
                                                            votes 
------------------------  ------------  -----------  ------------  --------- 
 6. Disapplication 
  of pre-emption rights    396,196,609   41,744,610   437,941,219      6,900 
------------------------  ------------  -----------  ------------  --------- 
 7. Authority to 
  purchase own shares      437,943,080        5,039   437,948,119          0 
------------------------  ------------  -----------  ------------  --------- 
 

Notes:

1. Any proxy votes which are at the discretion of the Chairman have been included in the 'For' total.

2. A vote 'Withheld' is not a vote in law and is not counted in the calculation of the proportion of the votes for and against a resolution.

A copy of the resolutions passed at the meeting is being uploaded today to the National Storage Mechanism and will shortly be available for viewing at www.morningstar.com.

The proxy figures for the resolutions will also be displayed on the Company website at www.cathay-intl.com.hk

- ENDS -

For further enquiries, please contact:

 
 Cathay International Holdings 
  Limited                               Tel: +852 2828 9289 
  Eric Siu (Finance Director) 
  Patrick Sung (Director and 
  Controller) 
 Consilium Strategic Communications 
  Mary-Jane Elliott / Matthew           Tel: +44 (0) 203 
  Neal / Lindsey Neville                709 5702 
 

About Cathay

Cathay International Holdings Limited (LSE: CTI.L) is a main market listed investment holding company and an operator and investor in the growing healthcare sector in the People's Republic of China (the "PRC"). The Company and its subsidiaries (collectively the "Group") aim to leverage on growth opportunities in the strong and growing domestic demand for high quality healthcare products in the PRC and build its portfolio companies into market sector leaders with competitive edge. Cathay has already demonstrated a strong track record of identifying high- growth potential investment opportunities in this area including: Lansen, a leading specialty pharmaceutical company focused on rheumatology and dermatology in the PRC; Haizi, a company engaged in the manufacture, marketing and sale of inositol and its by-product, di-calcium phosphate; Natural Dailyhealth, a company engaged in production and sales of plant extracts for use as key active ingredients in healthcare products; and Botai, a company engaged in collagen products.

The Group employs approximately 2,000 people across the PRC, including over 30 specialist corporate and business development staff based at the holding company's offices in Hong Kong and Shenzhen. Cathay also has a hotel investment. For more information please visit the Company's website: www.cathay-intl.com.hk.

This information is provided by RNS

The company news service from the London Stock Exchange

END

RAGFBMMTMBATBIR

(END) Dow Jones Newswires

June 21, 2017 06:55 ET (10:55 GMT)

1 Year Cathay International Hol... Chart

1 Year Cathay International Hol... Chart

1 Month Cathay International Hol... Chart

1 Month Cathay International Hol... Chart

Your Recent History

Delayed Upgrade Clock